PINK1 and gastric cancer: To examine whether the increased expression of PINK1 and ratio of LC3BII/I protect gastric cancer cells from cisplatin, SGC7901/DDP cells were transfected with PINK1 siRNAs to knockdown the expression of PINK1 or treated with PIK-III to down-regulate the ratio of LC3BII/I.